10 November 2026 Sofdra® receives the International Hyperhidrosis Society Seal of Recognition™ PHOENIX, USA – 10 November 2026: Commercial dermatology company, Botanix Pharmaceuticals Limited (ABN 70 009 109 755) (ASX:BOT, “Botanix” or “the Company”), is pleased to announce that...
Sofdra receives the International Hyperhidrosis Society Seal
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Botanix Pharmaceuticals Limited announces that its product Sofdra has received the International Hyperhidrosis Society Seal of Recognition. Botanix's CEO emphasized the importance of this recognition in encouraging discussions about hyperhidrosis between patients and doctors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Notification of cessation of securities - BOT
- Notice of Annual General Meeting/Proxy Form
- Application for quotation of securities - BOT
- Botanix Q1 FY27 Investor Update Webinar Presentation
- Botanix Quarterly Activities Report and Appendix 4C Q1 FY27
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals